TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
JSPR

Jasper Therapeutics Inc

Healthcare · Biotechnology

0.6178$ -2.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement JSPR
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0%
9.1% 9.7%
-9.1% -9.7%
410.3% 256.3%
184.2% 122.6%
594.5% 378.9%
-594.5% -378.9%
100.0% 100.0%
-494.5% -278.9%
-17.7% -100.0%
-494.5% -278.9%
-488.4% -271.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?